David A. Siegel Harrow Health, Inc. Transaction History
Two Sigma Advisers, LP
- $46.1 Billion
- Q2 2025
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Harrow Health, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 11,500 shares of HROW stock, worth $477,250. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,500
Previous 29,700
61.28%
Holding current value
$477,250
Previous $790,000
55.57%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding HROW
# of Institutions
181Shares Held
21.5MCall Options Held
390KPut Options Held
413K-
Opaleye Management Inc. Boston, MA3.91MShares$162 Million28.52% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$89.2 Million0.0% of portfolio
-
Private Capital Management, LLC Naples, FL1.95MShares$80.7 Million6.93% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$77.6 Million0.0% of portfolio
-
Braidwell LP Stamford, CT872KShares$36.2 Million1.63% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $1.12B
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...